Genenta Science S.p.A GNTA
NASDAQ GNTA
$0.63 -0.01 (-1.53%)
As of: Oct 22, 2026 · 1:15 PM EDT

Genenta Science S.p.A (GNTA) Receivables (2024)

Updated

Genenta Science S.p.A (GNTA) recorded Receivables of $115,408 in the quarter ended Dec 31, 2024.

Analysis

Genenta Science S.p.A (GNTA) Receivables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn 18.99 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn 13.82 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn 12.49 Bn
10 Genenta Science S.p.A 12.59 Mn -72.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 112,386.44
Jun 30, 2024 115,651.51
API Access

Genenta Science S.p.A Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GNTA&period=max&api_key=YOUR_API_KEY